| BCLI Snapshot | |
|---|---|
| Brainstorm Cell Therapeutics Inc., a biotechnology company, is dedicated to the development and commercialization of autologous cell therapies for the treatment of neurodegenerative diseases. The company is headquartered in New York, New York. | |
| VALUATION DATA | |
| Market Capitalization | $35,148,200 | Price to Sales | 1.00 |
| Earnings per Share | $-0.4000 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.5143 |
| 52 Week High | $- |
| 52 Week Low | $65.82 |
| 50-Day Moving Average | $- |
| 200-Day Moving Average | $-1.884 |
| All data are from Alpha Vantage as of today. For more infomation on BCLI see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search